Approval · Notice of Compliance 14378 · 2013
HALOPERIDOL INJECTION USP: Notice of Compliance 14378
Issued May 16, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14378
- Date
- May 16, 2013
- Company
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antipsychotic agent
- Canadian reference product
- HALOPERIDOL INJECTION (Omega Laboratories Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION USP | 02406411 | Marketed |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML